Moderna Shows Ambition With Flu Success And Cancer Therapy Expansion
Aiming For 15 Launches In Five Years
Slower COVID-19 vaccine sales will see Moderna’s revenues decline this year, but the company is investing heavily to speed a new wave of therapies to the market.
